Abstract
The objective of this study was to explore the mechanism of phosphatase and tensin homolog (PTEN) loss in endometriosis. We found that aberrant PTEN expression and mitogen-activated protein kinases (MAPK)/ERK, phosphoinositide 3-kinase (PI3K)/AKt, and nuclear factor-kappaB (NFκB) signaling overactivities coexisted in endometriosis. In vitro, 17β-estradiol rapidly activated the 3 pathways in endometriotic cells and specific inhibitions on the 3 pathways respectively blocked 17β-estradiol-induced cell proliferation. 17β-estradiol suppressed PTEN transcription and expression in endometriotic cells which was abolished by specific NFκB inhibition. Conclusion(s) Total/nuclear PTEN-loss and MAPK/ERK, PI3K/AKt, and NFκB signal overactivities coexist in endometriosis. In vitro, 17β-estradiol can promotes cell proliferation in endometriosis by activating PI3K/AKt pathway via an NFκB/PTEN-dependent pathway. For the first time we propose the possibility of the presence of a positive feedback-loop: 17β-estradiol → high NFκB → low PTEN → high PI3K → high NFκB, in endometriosis, which may finally promote the proliferation of ectopic endometrial epithelial cells and in turn contributes to the progression of the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
